6-K

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                           ---------------------------


                                    FORM 6-K

                        REPORT OF FOREIGN PRIVATE ISSUER
                      PURSUANT TO RULE 13A-16 OR 15D-16 OF
                       THE SECURITIES EXCHANGE ACT OF 1934


For the month of April, 2005


Commission File Number 000-28996


                                    --------


                                 ELSCINT LIMITED
                 (Translation of Registrant's Name Into English)


                  13 NOAH MOZES STREET, TEL AVIV 67442, ISRAEL
                    (Address of principal executive offices)



      Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
      Form 20-F  X            Form 40-F
                ---                    ---

      Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1): ____

      Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7): ____

      Indicate by check mark whether the registrant by furnishing the
information contained in this form is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
      Yes                     No  X
         ---                    ----

      If "Yes is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b):  82-          .
                                                  ----------






                                EXPLANATORY NOTE

Attached are the following exhibits:

99.1  Press release, released publicly on April 14, 2005.







                                    SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                       ELSCINT LIMITED
                                       ---------------
                                       (Registrant)


Date: April 14, 2005                   By: /s/ Rachel Lavine
                                          ----------------------
                                          Name: Rachel Lavine
                                          Title: President









                                  EXHIBIT INDEX

EXHIBIT NO.       DESCRIPTION
- -----------       -----------

99.1  Press release, released publicly on April 14, 2005.

EX-99

                                                                    Exhibit 99.1


                                [GRAPHIC OMITTED]

       ELSCINT AND ELBIT MEDICAL UPDATE PARTICIPATION IN JOINT VENTURE FOR
                            TELEVISION CHANNEL TENDER


Tel Aviv, Israel - April 14, 2005 - Elscint Limited (NYSE: ELT) (the "Company")
today announced that, further to its announcement of February 2nd, 2005
regarding the joint participation of the Company and Elbit Medical Imaging
("EMI"), the controlling shareholder of the Company, in a joint venture
("Canne"); the Second Television and Radio Authority informed Canne that it was
not included among the winning groups in the tender.


Elscint Limited has interests in hotels in Western Europe, in hotel development
projects principally in Western and Central Europe and in the "Arena" commercial
and entertainment center at Herzlia Marina in Israel. More information regarding
the Company is available at: http://www.elscint.net

This release contains certain forward-looking statements which involve known and
unknown risks, uncertainties or other factors not under the Company's control
which may cause actual results, performance or achievements of the Company to be
materially different from the results, performance or other expectations implied
by these forward-looking statements. These factors include, but are not limited
to, those detailed in the Company's periodic filings with the Securities and
Exchange Commission.

                                                      For Further Information:

Company Contact                               Investor Contact
Marc Lavine, Adv.                             Kathy Price
Elscint Limited                               The Anne McBride Company
+ 972-3-608-6001                              + 212-983-1702 x212
mlavine@elscint.net                           kprice@annemcbride.com
- -------------------